The Company is a Korea-based company principally engaged in the next generation diagnostic testing platform business. The Company is engaged in the manufacture and sale of blood test diagnostic devices based on the artificial intelligence (AI) algorithms and diagnostic kits. In addition, the Company is also engaged in the provision of services such as regular monthly subscriptions and others through an integrated web-based remote diagnosis system. The Company was established on December 2, 2015. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on March 3, 2022.
Headquarters
B-dong, 10th Floor, 338, Gwanggyojungang-ro Suji-gu Yongin-si Gyeonggi
Yongin; Gyeonggi;
Contact Details: Purchase the Noul Co.,Ltd. report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service